---All---
  • ---All---
  • Accession
  • Catalog #

GZMM Antibody (Center)Purified Rabbit Polyclonal Antibody (Pab)

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AP6792c 0.1 mg 400 ul In Stock $ 255.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

GZMM Antibody (Center) - Product info

ApplicationWB, IHC, FC
  • Applications Legend:
  • W=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • F=Flow Cytometry
Primary AccessionP51124
ReactivityHuman
Concentration0.25 mg/ml
IsotypeRabbit Ig
Calculated MW27545 Da

GZMM Antibody (Center) - Additional info

Gene ID 3004
Other Names
GZMM; MET1; Granzyme M; Met-1 serine protease; Met-ase; Natural killer cell granular protease
Target/Specificity
This GZMM antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 91~121 amino acids from the Center region of human GZMM.
Dilution
WB~~1:100~500
IHC~~1:10~50
FC~~1:10~50
Format
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
GZMM Antibody (Center) is for research use only and not for use in diagnostic or therapeutic procedures.

GZMM Antibody (Center) - Protein Information

Name GZMM
Synonyms MET1
Function
Cleaves peptide substrates after methionine, leucine, and norleucine. Physiological substrates include EZR, alpha- tubulins and the apoptosis inhibitor BIRC5/Survivin. Promotes caspase activation and subsequent apoptosis of target cells
Cellular Location
Secreted. Cytoplasmic granule. Note=Granules of large granular lymphocytes
Tissue Location
Highly and constitutively expressed in activated natural killer (NK) cells

GZMM Antibody (Center) - Related products

AP6792c: GZMM Antibody (Center)

RI12387: GZMM predesign siRNA

DC05498: Human GZMM cDNA Clone

LY11981a: GZMM Over-expression Lysate

BP6792c: GZMM Antibody (Center) Blocking Peptide

AT2305a: GZMM Antibody (monoclonal) (M03)

GZMM Antibody (Center) - Application data

  • Western blot analysis of GZMM Antibody (Center) (Cat. #AP6792c) in K562 cell line lysates (35ug/lane). GZMM (arrow) was detected using the purified Pab.

  • GZMM Antibody (Center) (Cat. #AP6792c) IHC analysis in formalin fixed and paraffin embedded human lymph tissue followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the GZMM Antibody (Center) for immunohistochemistry. Clinical relevance has not been evaluated.

  • GZMM Antibody (Center) (Cat. #AP6792c) flow cytometric analysis of K562 cells (bottom histogram) compared to a negative control cell (top histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.

GZMM Antibody (Center) - Research Areas

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

GZMM cleaves peptide substrates after methionine, leucine, and norleucine.

REFERENCES

Mahrus,S., et.al., J. Biol. Chem. 279 (52), 54275-54282 (2004)